SCHEMBL6084433

SCHEMBL6084433

COc1cc(C(=O)Nc2ccc(-c3n[nH]cc3-c3nc4cc5ccccc5cc4o3)cc2)cc(OC)c1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.63
TP53 P04637 6/20 0.61
THRB P10828 2/20 0.59
HSD17B10 Q99714 6/20 0.55
HPGD P15428 5/20 0.55
KDM4E B2RXH2 4/20 0.55
ALDH1A1 P00352 4/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
HTT P42858 2/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
GAA P10253 2/20 0.53
USP2 O75604 2/20 0.52
TSHR P16473 1/20 0.52
STAT3 P40763 1/20 0.52
NPSR1 Q6W5P4 1/20 0.51
PTGS2 P35354 3/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6085695 0.91 PTGS2 (0.60) MAPTTP53THRBHSD17B10HPGD
SCHEMBL6085942 0.88 MAPT (0.61) MAPTTP53THRBHSD17B10HPGD
SCHEMBL6084107 0.86 UTRN (0.49) MAPTTP53THRBHSD17B10HPGD
SCHEMBL6083913 0.86 MAPT (0.48) MAPTTP53THRBHSD17B10HPGD
SCHEMBL6085202 0.86 MAPT (0.48) MAPTTP53THRBHSD17B10HPGD
SCHEMBL6086408 0.84 MAPT (0.53) MAPTTP53MEN1KMT2AHTT
SCHEMBL6086106 0.82 MAPT (0.55) MAPTTP53THRBHSD17B10HPGD
SCHEMBL6085902 0.82 SMN1; SMN2 (0.49) MAPTTP53THRBHSD17B10HPGD
SCHEMBL6085194 0.82 MAPT (0.53) MAPTTP53THRBHSD17B10HPGD
SCHEMBL6084598 0.80 MAPT (0.62) MAPTTP53THRBHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105535-B2 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2006-09-12 US claimed
EP-1377589-B1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2005-09-07 EP claimed
US-20040180881-A1 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2004-09-16 US claimed
EP-1377589-A1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-07 EP claimed
WO-2002062804-A1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2002-08-15 WO claimed
US-7105535-B2 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2006-09-12 US disclosed
EP-1377589-B1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2005-09-07 EP disclosed
US-20040180881-A1 Oxazolyl-pyrazole derivatives as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180881-A1 Oxazolyl-pyrazole derivatives as kinase inhibitors MAP3K15, MAP3K20, MAP3K3 MAPT 801/4885TP53 466/4885THRB 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.